Recent studies have identified some adverse prognostic factors associated with survival in patients with T1-2N1 breast cancer, including young age, greater lymph node disease burden, large tumor size, high histological grade, lymphovascular invasion, and negative hormone receptors (3, 7, 14, 15, 17, 20–27). The gene discussed is NR4A1; the disease is lymph node disorder.